ID23013A - Bahan-bahan farmakologi - Google Patents
Bahan-bahan farmakologiInfo
- Publication number
- ID23013A ID23013A IDW991132A ID991132A ID23013A ID 23013 A ID23013 A ID 23013A ID W991132 A IDW991132 A ID W991132A ID 991132 A ID991132 A ID 991132A ID 23013 A ID23013 A ID 23013A
- Authority
- ID
- Indonesia
- Prior art keywords
- pharmacological ingredients
- pharmacological
- ingredients
- Prior art date
Links
- 239000004615 ingredient Substances 0.000 title 1
- 230000000144 pharmacologic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4279597P | 1997-04-07 | 1997-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID23013A true ID23013A (id) | 1999-12-30 |
Family
ID=21923795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW991132A ID23013A (id) | 1997-04-07 | 1998-04-06 | Bahan-bahan farmakologi |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6242462B1 (id) |
| EP (1) | EP0980358A4 (id) |
| JP (1) | JP2001521505A (id) |
| KR (1) | KR20010006075A (id) |
| CN (1) | CN1259126A (id) |
| AU (1) | AU734657B2 (id) |
| BR (1) | BR9809071A (id) |
| CA (1) | CA2285192A1 (id) |
| EA (1) | EA199900912A1 (id) |
| HU (1) | HUP0002030A3 (id) |
| ID (1) | ID23013A (id) |
| IL (1) | IL132086A0 (id) |
| NO (1) | NO994850L (id) |
| NZ (1) | NZ337827A (id) |
| PL (1) | PL336068A1 (id) |
| TR (1) | TR199902449T2 (id) |
| WO (1) | WO1998045270A1 (id) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE240299T1 (de) * | 1999-07-06 | 2003-05-15 | Lilly Co Eli | Diester prodrugs von decahydroischinoline-3- carbonsäure |
| PT1200073E (pt) | 1999-07-06 | 2007-03-30 | Lilly Co Eli | Antagonistas selectivos do receptor de iglur5 para o tratamento de enxaqueca |
| AU2574801A (en) | 1999-12-22 | 2001-07-03 | Eli Lilly And Company | Selective iGLUR5 receptor antagonists |
| US6924294B2 (en) | 2001-01-05 | 2005-08-02 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| AU2002227020A1 (en) | 2001-01-05 | 2002-07-16 | Eli Lilly And Company | Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists |
| AU2002228736A1 (en) | 2001-01-05 | 2002-07-16 | Eli Lilly And Company | Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists |
| AU2002241565A1 (en) * | 2001-01-05 | 2002-07-16 | Eli Lilly And Company | Excitatory amino acid receptor antagonist and 5-ht1f agonist combination: a method for the treatment of neurological disorders |
| US7205313B2 (en) | 2001-01-05 | 2007-04-17 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| CN100548299C (zh) * | 2001-01-05 | 2009-10-14 | 伊莱利利公司 | 兴奋性氨基酸受体拮抗剂 |
| WO2002058691A1 (en) * | 2001-01-23 | 2002-08-01 | Neurosearch A/S | Use of non-competitive and selective glur5 antagonists as glutamate receptor modulating compounds |
| EP1511741B1 (en) | 2002-04-26 | 2012-12-26 | Eli Lilly And Company | Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics |
| US20050101597A1 (en) * | 2003-07-10 | 2005-05-12 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitior and a non-NMDA glutamate modulator for the treatment of central nervous system damage |
| EP1715921B1 (en) * | 2003-09-25 | 2013-04-24 | Abraxis BioScience, Inc. | Tetrahydroindolone derivatives for treatment of neurological conditions |
| US20050107439A1 (en) * | 2003-11-10 | 2005-05-19 | Helton David R. | Composition and method for treating emesis |
| PL2083811T3 (pl) | 2006-11-22 | 2017-05-31 | Clinical Research Associates, Llc | Sposoby leczenia zespołu downa, zespołu łamliwego chromosomu x oraz autyzmu |
| EP2150248A4 (en) | 2007-01-16 | 2011-06-29 | Univ Johns Hopkins | GLUTAMATE RECEPTOR ANTAGONISTS AND METHOD OF USE |
| EP2219648A4 (en) * | 2007-11-09 | 2010-11-03 | Cenomed Biosciences Llc | TREATMENT OF POSTRAUMATIC STRESS WITH TETRAHYDROINDOLONE ARYLPIPERAZINE COMPOUNDS |
| US20090264443A1 (en) * | 2008-04-18 | 2009-10-22 | David Helton | Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds |
| WO2011109398A2 (en) | 2010-03-02 | 2011-09-09 | President And Fellows Of Harvard College | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| US20110294879A1 (en) | 2010-05-28 | 2011-12-01 | Xenoport, Inc. | Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders |
| WO2012009646A1 (en) | 2010-07-15 | 2012-01-19 | Xenoport, Inc. | Methods of treating fragile x syndrome, down's syndrome, autism and related disorders |
| KR101746944B1 (ko) * | 2015-09-23 | 2017-06-14 | 주식회사 포스코 | 도장 선영성이 우수한 도금강판의 제조방법 및 이에 의해 제조된 도금강판 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| US5446051A (en) * | 1994-05-31 | 1995-08-29 | Eli Lilly And Company | Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitatory amino acid receptor antagonists |
| JPH11501619A (ja) * | 1995-02-15 | 1999-02-09 | ベアーズデン バイオ，インコーポレイテッド | アルキルカルボキシアミノ酸−カイネートレセプターのモジュレーター |
-
1998
- 1998-04-06 EA EA199900912A patent/EA199900912A1/ru unknown
- 1998-04-06 PL PL98336068A patent/PL336068A1/xx unknown
- 1998-04-06 HU HU0002030A patent/HUP0002030A3/hu unknown
- 1998-04-06 AU AU69555/98A patent/AU734657B2/en not_active Ceased
- 1998-04-06 JP JP54212798A patent/JP2001521505A/ja active Pending
- 1998-04-06 KR KR1019997009153A patent/KR20010006075A/ko not_active Withdrawn
- 1998-04-06 CN CN98805687A patent/CN1259126A/zh active Pending
- 1998-04-06 EP EP98915346A patent/EP0980358A4/en not_active Withdrawn
- 1998-04-06 IL IL13208698A patent/IL132086A0/xx unknown
- 1998-04-06 WO PCT/US1998/006905 patent/WO1998045270A1/en not_active Ceased
- 1998-04-06 NZ NZ337827A patent/NZ337827A/xx unknown
- 1998-04-06 BR BR9809071-2A patent/BR9809071A/pt not_active IP Right Cessation
- 1998-04-06 CA CA002285192A patent/CA2285192A1/en not_active Abandoned
- 1998-04-06 TR TR1999/02449T patent/TR199902449T2/xx unknown
- 1998-04-06 US US09/402,174 patent/US6242462B1/en not_active Expired - Fee Related
- 1998-04-06 ID IDW991132A patent/ID23013A/id unknown
-
1999
- 1999-10-05 NO NO994850A patent/NO994850L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0980358A4 (en) | 2001-02-07 |
| JP2001521505A (ja) | 2001-11-06 |
| HUP0002030A2 (hu) | 2001-04-28 |
| IL132086A0 (en) | 2001-03-19 |
| EA199900912A1 (ru) | 2000-04-24 |
| US6242462B1 (en) | 2001-06-05 |
| NO994850D0 (no) | 1999-10-05 |
| WO1998045270A1 (en) | 1998-10-15 |
| NO994850L (no) | 1999-10-05 |
| PL336068A1 (en) | 2000-06-05 |
| TR199902449T2 (xx) | 2000-07-21 |
| KR20010006075A (ko) | 2001-01-15 |
| EP0980358A1 (en) | 2000-02-23 |
| CN1259126A (zh) | 2000-07-05 |
| BR9809071A (pt) | 2000-08-01 |
| AU734657B2 (en) | 2001-06-21 |
| CA2285192A1 (en) | 1998-10-15 |
| HUP0002030A3 (en) | 2002-01-28 |
| NZ337827A (en) | 2000-12-22 |
| AU6955598A (en) | 1998-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA93198A (de) | Fluoxetinpellets | |
| ID23013A (id) | Bahan-bahan farmakologi | |
| ATA111897A (de) | Kimme | |
| NO20002555D0 (no) | Skjøt | |
| ATE236897T1 (de) | 3-benzylpiperidine | |
| ID24110A (id) | Pembuatan rutenium kompleks | |
| ID20403A (id) | PEMBUATAN α-TOKOFEROL | |
| ID20897A (id) | Susunan penutup-rapat | |
| FI970798A0 (fi) | List foer en avvattningsanordning i en pappersmaskin | |
| DE69838302D1 (de) | Gruppenlaufzeitentzerrer | |
| ID23663A (id) | Persiapan kaprolaktam | |
| FI972138A0 (fi) | Returtraog i bestrykningsanordning | |
| ATA86797A (de) | Verschleissschuh | |
| ATA46498A (de) | Kunststoffgleitbahn | |
| ATA188297A (de) | Beschlag | |
| ITDP970013A1 (it) | Ruota singola - attrezzo sportivo - cicloidi | |
| ATA159297A (de) | Immuntolerante prothrombinkomplex-präparation | |
| FI971698A0 (fi) | Klingstyrenhet i en cirkelsaog | |
| FI971123A0 (fi) | Foervarings- och transportredskap i synnerhet foer pappersprodukter | |
| BR9701099A (pt) | Acertrol i | |
| FI971651A0 (fi) | Spaormaskin i en elmaskin | |
| FI972640A0 (fi) | Gapformare i en pappersmaskin/kartongmaskin | |
| FI974635A0 (fi) | I vaermebatteri integrerbar ventilkonstruktion | |
| FI974373A0 (fi) | Avgasutlopp i utombordsmotorer | |
| FI974354A0 (fi) | Kvaevereducering i avloppsvatten |